MedTrace Logo

Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling

NCT04341363 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2023-06-18

Study results available
· View outcomes & findings →

Summary

The intent of this study is to evaluate the efficacy of microneedling through use of a professional tattoo machine in hair regrowth in patients with androgenic alopecia (AGA) over up to 6 treatments (6 months).

Conditions

  • Androgenic Alopecia

Interventions

DEVICE

Tattoo machine

A SOL Nova Device (brand) tattoo machine will be used to stimulate hair regrowth.

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Brett King, MD, PhD · Associate Professor of Dermatology, Yale University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-09
Primary Completion
2022-05-02
Completion
2022-05-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04341363 on ClinicalTrials.gov